Mirava Bio is a BioCommercial Partner supporting emerging rare disease biotechs in defining the optimal cross-functional go-to-market strategy in EMEE and executing it through our fully licence-ready, plug-and-play commercialization platform, reducing financial risk, accelerating patient access, and preserving ownership across Europe, the Middle East, and Eurasia.